Study of SI-B036 for advanced head and neck and other solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called SI-B036 for people whose head and neck cancer or other solid tumor has spread or cannot be removed surgically. The goal is to see if the drug can shrink tumors or slow their growth. The drug is given by infusion and works by targeting cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old, but not older than 75.
- You have a head and neck or other solid tumor that has spread or cannot be removed by surgery.
- You are able to provide a tissue sample (old, from the past 2 years, or a fresh biopsy).
- You have at least one lesion that can be measured on imaging scans (like CT or MRI).
- You are physically active (can do light housework or desk work) and are expected to live at least 3 more months.
- Your overall health is good enough to receive the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, SI-B036, in people with advanced gynecological cancers or other solid tumors that have spread. The goal is to see if the drug is safe and effective in shrinking tumors or slowing their growth.
This study tests an experimental drug called BL-M08D1 for people with head and neck cancer that has returned or spread. The drug is designed to target and destroy cancer cells, and the study will check if it is safe and how well it works.
This study tests a new drug called SI-B036 for people with advanced breast cancer or other solid tumors that have spread. The goal is to see if the drug is safe and to find the best dose.
This early-stage trial tests a new drug called SI-B036 in patients with advanced cancers that have spread or cannot be completely removed by surgery. The goal is to understand how safe the drug is and how well it works.
This trial tests a new drug called SI-B036 in people with advanced digestive tract or other solid tumors that have spread. It aims to see if the drug is safe and effective. You may qualify if you have a measurable tumor and are in relatively good health.
This trial tests a new drug called SI-B036 for people with advanced urinary tract cancers or other solid tumors that have spread or cannot be removed. The goal is to see if the drug can shrink or stabilize the cancer.
Hear when a new Head and Neck Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.